Surging biotech industry amid strong Sino-Australian trade relations

AusBiotech, the trade federation that represents the Australian biotechnology industry, is to hold a series of investment events in Asian financial hubs next month.

Asian investors have shown strong interest in the burgeoning Australian biotechnology industry, which was valued at A$81 billion in 2016. Last year companies in this area attracted over A$1.3 billion of capital investment.

Chinese investment in particular has been growing strongly in recent years, driven by the China-Australia Free Trade Agreement (ChAFTA), which entered into force in 2015. China now invests around A$75 billion per year in Australia, up from $2 billion a decade ago.